Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 181

1.

Impact of a pharmaceutical care program in a community pharmacy on patients with dyslipidemia.

Paulós CP, Nygren CE, Celedón C, Cárcamo CA.

Ann Pharmacother. 2005 May;39(5):939-43.

PMID:
15827075
2.

Clinical and humanistic outcomes of a lipid management program in the community pharmacy setting.

Nola KM, Gourley DR, Portner TS, Gourley GK, Solomon DK, Elam M, Regel B.

J Am Pharm Assoc (Wash). 2000 Mar-Apr;40(2):166-73. Erratum in: J Am Pharm Assoc (Wash). 2000 Sep-Oct;40(5):583.

PMID:
10730020
3.

Statin therapy helps to control blood pressure levels in hypertensive dyslipidemic patients.

Kanbay M, Yildirir A, Bozbas H, Ulus T, Bilgi M, Muderrisoglu H, Akcay A, Ozdemir FN.

Ren Fail. 2005;27(3):297-303.

PMID:
15957546
4.

Effect of intervention through a pharmaceutical care program on patient adherence with prescribed once-daily atorvastatin.

Vrijens B, Belmans A, Matthys K, de Klerk E, Lesaffre E.

Pharmacoepidemiol Drug Saf. 2006 Feb;15(2):115-21.

PMID:
16342302
6.

Improving primary care in rural Alabama with a pharmacy initiative.

Taylor CT, Byrd DC, Krueger K.

Am J Health Syst Pharm. 2003 Jun 1;60(11):1123-9.

PMID:
12816022
7.

Impact of pharmacist-conducted home visits on the outcomes of lipid-lowering drug therapy.

Peterson GM, Fitzmaurice KD, Naunton M, Vial JH, Stewart K, Krum H.

J Clin Pharm Ther. 2004 Feb;29(1):23-30.

PMID:
14748894
8.

Improving drug therapy for patients with asthma--part 1: Patient outcomes.

Herborg H, Soendergaard B, Froekjaer B, Fonnesbaek L, Jorgensen T, Hepler CD, Grainger-Rousseau TJ, Ersboell BK.

J Am Pharm Assoc (Wash). 2001 Jul-Aug;41(4):539-50.

PMID:
11486980
9.

Pharmaceutical care research and education project: patient outcomes.

Volume CI, Farris KB, Kassam R, Cox CE, Cave A.

J Am Pharm Assoc (Wash). 2001 May-Jun;41(3):411-20.

PMID:
11372906
10.

A pharmacotherapy follow-up program in patients with type-2 diabetes in community pharmacies in Spain.

Fornos JA, Andrés NF, Andrés JC, Guerra MM, Egea B.

Pharm World Sci. 2006 Apr;28(2):65-72.

PMID:
16791717
11.

Pharmaceutical care for migraine and headache patients: a community-based, randomized intervention.

Hoffmann W, Herzog B, Mühlig S, Kayser H, Fabian R, Thomsen M, Cramer M, Fiss T, Gresselmeyer D, Janhsen K.

Ann Pharmacother. 2008 Dec;42(12):1804-13. doi: 10.1345/aph.1K635.

PMID:
19001531
12.

Comprehensive pharmaceutical care in the chain setting.

Park JJ, Kelly P, Carter BL, Burgess PP.

J Am Pharm Assoc (Wash). 1996 Jul;NS36(7):443-51.

PMID:
8840744
13.

Evaluation of a pharmaceutical care program for hypertensive patients in rural Portugal.

Garção JA, Cabrita J.

J Am Pharm Assoc (Wash). 2002 Nov-Dec;42(6):858-64.

PMID:
12482009
14.

Effects of a stanol-enriched diet on plasma cholesterol and triglycerides in patients treated with statins.

Castro Cabezas M, de Vries JH, Van Oostrom AJ, Iestra J, van Staveren WA.

J Am Diet Assoc. 2006 Oct;106(10):1564-9.

PMID:
17000189
15.

Effectiveness of rosuvastatin versus atorvastatin in reducing lipid levels and achieving low-density-lipoprotein cholesterol goals in a usual care setting.

Bullano MF, Kamat S, Wertz DA, Borok GM, Gandhi SK, McDonough KL, Willey VJ.

Am J Health Syst Pharm. 2007 Feb 1;64(3):276-84.

PMID:
17244877
16.

Effects of collaborative drug therapy management on patients' perceptions of care and health-related quality of life.

Isetts BJ, Schondelmeyer SW, Heaton AH, Wadd WB, Hardie NA, Artz MB.

Res Social Adm Pharm. 2006 Mar;2(1):129-42.

PMID:
17138505
17.

Focused atorvastatin therapy in managed-care patients with coronary heart disease and CKD.

Koren MJ, Davidson MH, Wilson DJ, Fayyad RS, Zuckerman A, Reed DP; ALLIANCE Investigators..

Am J Kidney Dis. 2009 May;53(5):741-50. doi: 10.1053/j.ajkd.2008.11.025.

PMID:
19216014
18.

Dyslipidemia control in indigent patients receiving medication assistance compared with insured patients.

Marrs JC, Saseen JJ.

Pharmacotherapy. 2008 May;28(5):562-9. doi: 10.1592/phco.28.5.562.

PMID:
18447654
19.

Development and evaluation of a patient-oriented education system for diabetes management.

Lee TI, Yeh YT, Liu CT, Chen PL.

Int J Med Inform. 2007 Sep;76(9):655-63.

PMID:
16815741
20.

Pharmaceutical care services and results in project ImPACT: hyperlipidemia.

Bluml BM, McKenney JM, Cziraky MJ.

J Am Pharm Assoc (Wash). 2000 Mar-Apr;40(2):157-65.

PMID:
10730019
Items per page

Supplemental Content

Support Center